文献速递腹部MR

基于MRI的影像组学生物标志物用于无创评估MASLD肝纤维化:大鼠模型中的诊断性能与分子机制

MRI-Based Radiomic Biomarkers for Non-invasive Assessment of Liver Fibrosis in MASLD: Diagnostic Performance and Molecular Mechanisms in a Rat Model.
PubMed 文献 · Acad Radiol · 2025-06-26

研究用146只雄性Sprague-Dawley大鼠随机分为训练队列87只和测试队列59只,基于多参数MRI构建12特征影像组学风险评分(Radscore)。该评分检测肝纤维化(F0 vs ≥F1)的AUC在训练队列为0.90、测试队列为0.89,分期(≤F2 vs ≥F3)的AUC分别为0.97和0.96;32份肝组织转录组测序显示Radscore与10个纤维化相关基因正相关、与10个线粒体功能和血管完整性相关基因负相关。

要点

  • Radscore基于T2FS、PDFF、同相位和反相位多参数MRI的12个影像组学特征构建。
  • 检测F0 vs ≥F1的AUC训练队列0.90、测试队列0.89;分期≤F2 vs ≥F3的AUC分别为0.97和0.96。
  • Radscore与细胞外基质重塑和炎症相关基因正相关,与线粒体功能和血管完整性相关基因负相关。

核心结论

  • Radscore有望作为MASLD肝纤维化的无创影像生物标志物,其与转录组改变的相关性提示潜在的生物学相关性,为未来在精准医学框架下研究影像基因组学联系奠定基础。

研究设计与样本

  • 研究纳入146只雄性Sprague-Dawley大鼠,随机分为训练队列87只和测试队列59只,获取T2FS、PDFF、同相位和反相位多参数MRI序列,采用LASSO回归和冗余分析构建12特征Radscore,并对32份肝组织进行转录组测序。

诊断标准与关键数值

  • Radscore检测肝纤维化(F0 vs ≥F1)的AUC在训练队列为0.90、测试队列为0.89;纤维化分期(≤F2 vs ≥F3)的AUC在训练队列为0.97、测试队列为0.96。

局限性

  • 原文结论指出其与转录组改变的相关性提示潜在生物学相关性,并为未来研究影像基因组学联系奠定基础,原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Accurate, non-invasive assessment of liver fibrosis (LF) remains a clinical challenge. This study aimed to develop a MRI-based radiomic risk score (Radscore) for staging LF and to explore the biological relevance of radiomic features using transcriptomic analysis.

MATERIALS AND METHODS: A total of 146 male Sprague-Dawley rats were split into two cohorts at random: 87 for training and 59 for testing. T2-weighted fat-suppressed (T2FS), proton density fat fraction (PDFF), in-phase, and out-of-phase images were among the multiparametric MRI sequences obtained. After radiomic features were collected, LASSO regression and redundancy analysis were used to create a 12-feature Radscore. The achieving area under the curve (AUC) was applied to assess the diagnostic performance of the Radscore for liver fibrosis detection (F0 vs. ≥F1) and staging (≤F2 vs. ≥F3). Additionally, 32 liver tissues underwent transcriptome sequencing. Radscore-associated genes were found using Pearson correlation, weighted gene co-expression network analysis (WGCNA), and differential expression analysis. Functional enrichment analysis was then performed.

RESULTS: The Radscore demonstrated robust diagnostic performance in detecting liver fibrosis, with AUC values of 0.90 in the training cohort and 0.89 in the testing cohort (F0 vs. ≥F1). For fibrosis staging (≤F2 vs. ≥F3), the AUCs were 0.97 and 0.96, respectively. Furthermore, the Radscore was positively correlated with 10 fibrosis-associated genes (e.g., Col1a1, Col1a2, Ptprc) involved in extracellular matrix remodeling and inflammatory processes. In contrast, it exhibited negative correlations with 10 genes related to mitochondrial function and vascular integrity (e.g., Ndufa7, Cox5b, Kdr).

CONCLUSION: The Radscore shows promise as a non-invasive imaging biomarker for liver fibrosis in MASLD. Its correlation with transcriptomic alterations indicates potential biological relevance, establishing a foundation for future studies investigating radiogenomic connections within the framework of precision medicine.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Li F, Liang Y, Xia X, et al. MRI-Based Radiomic Biomarkers for Non-invasive Assessment of Liver Fibrosis in MASLD: Diagnostic Performance and Molecular Mechanisms in a Rat Model. Acad Radiol. 2025. PMID: 40579256. doi:10.1016/j.acra.2025.05.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。